SC02 - Overview and Essential Methods of Drug Utilization Research

Live Q&A Session
Monday, December 7, 2020
9-10 AM
Watch the Q&A

Description: This educational program provides an overview of drug utilization research (DUR), presenting essential methods for basic to advanced drug utilization studies. Participants will be exposed to:
Description of the theoretical framework and practical applications of methods used in drug utilization research using selected examples
Classification systems used in drug utilization monitoring and research
Benefits and potential limitations of data sources, study design and analytical methods
Interpretation of aggregate and individual-based data, variation and change
Using drug utilization research to improve drug use, and evaluate the effects of clinical and policy decisions on drug utilization
Application of principles derived from Health Services and Implementation Research to the design of a clinical intervention
Use of prescribing data and quality measures to assess prescribing

Objectives:
This course is targeted at:
Members (including new members) of the DUR / HSR SIG
Graduate students interested in all DUR methodologies
Those interested in monitoring of medicine use and quality assessment
Those interested in quality development and implementation research, knowledge transfer, evaluation of interventions, health and medicines policy areas, health funds and third-party payers
Clinical pharmacoepidemiologists, health service planners, clinical guidelines developers, health practitioners
Outline
All presentations will include a working practical example of conducting DUR in practice, relevant to each of the topics.
Doug Steinke, Associate Professor in Pharmacoepidemiology, Division of Pharmacy & Optometry, The University of Manchester. Drug Utilisation Research SIG, Chair. Welcome and An Introduction to Drug Utilisation Research and Principles
Lisa Pont, Associate Professor, University of Technology Sydney, Australia, University of Groningen, The Netherlands. Drug Utilisation Research: Methodological Framework and Skills Needed
Bjorn Wettermark, Professor, Centre for Pharmacoepidemiology, Karolinska Institute, Stockholm, Sweden. Study Designs and Epidemiological Measures of Drug Use
Katja Taxis, Professor of Pharmacotherapy and Pharmaceutical Care, University of Groningen, The Netherlands. Introduction, Overview and Design of Interventions to Improve Quality of Medicine Use
Lisa Kalisch Ellett, NHMRC-ARC Dementia Research Development Fellow, Quality Use of Medicines and Pharmacy Research Centre, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia. Designs to Evaluate Interventions on Drug Utilisation: Clinical and Policy Perspectives
Petra Denig, Professor, Faculty of Medical Sciences, University of Groningen, Groningen, Netherlands. Assessment of Outcomes (Donabedian model of quality of care, Prescribing Quality Indicators, Adverse Outcomes, Adherence)